Risk of Recurrence Testing

Integrate a tumor profiling test into the clinical decision-making process   Evaluate benefit of chemotherapy in cases where uncertainty still exists about its utility   Reduce chemotherapy over-treatment in those likely to be optimally treated with hormone therapy alone   Reduce inadequate treatment by identifying individuals who derive great benefit from chemotherapy